The actual duration that effects will have, is highly dependent upon factors such as the lifestyle and physiology of the patient. However, it has been noted that on average, visible results can last for 3 to 6 months from the date the injection was performed.

Start off the treatment plan with an insertion of 1.25-2.5 units (0.05-0.1 mL at each location) into the inner and outer sections of the upper eyelid’s orbicularis oculi muscular tissue, in addition to the outer region of the lower eyelid’s orbicularis oculi muscular tissue. For each patient, the maximum initial dos-age should be 25 units per eye, and the total dosage should not exceed 100 units within a three month period.

This medication is indicated specifically for the following uses:

• The treatment of blepharospasm (uncontrolled eye twitching) related to dystonia, including a benign essential blepharospasm, hemifacial spasm, or VIIth nerve disorders in any patient who is 12 years and older.
• The management of the condition of spasmodic torticollis (uncontrolled neck muscle contractions), also known as cervical dystonia, occurring in adults.
• The treatment of dynamic equinus foot deformity, due to muscular stiffness in pediatric cerebral palsy patients aged 2 years and above.
• Providing relief from the onset of excessive sweat (hyperhidrosis) in the underarm area.
• The management of urinary incontinence, which has resulted from neurogenic detrusor over-activity, such as that which is caused by spinal cord injury or onset of multiple sclerosis in adults.
• The correction of cross-eyes (strabismus) condition in a patient aged 12 years and older.
• The temporary treatment of frown lines (glabellar lines) which are linked with corrugator and/or procerus muscular activity, in a patient under 65 years of age.
• The treatment of focal muscular stiffness, including muscle stiffness which is associated with stroke.
• The temporary enhancement of the physical appearance of upper facial wrinkles, such as frown lines, crow’s feet, and forehead lines.
• The prevention of headaches occurring in a patient who has been afflicted with chronic migraines.

Meditoxin®, a product produced by Medytox Inc., is a type A botulinum toxin. Since introduction, it has become highly renowned for having a high level of safety and quality standards. This product, known as a botulinum toxin type A, functions by means of blocking nerve signals from being sent to specific muscular tissue, thereby enabling these same muscular tissues to refrain from contracting, instead remaining relaxed. This formulation is specifically developed to aid in the treatment of benign essential blepharospasm in a patient. Furthermore, it is utilized to treat equinus foot deformity, a condition most commonly triggered by spasticity, particularly when treatment is provided to a patient diagnosed with cerebral palsy. The treatment for these conditions works through relaxation of the muscular tissue. After treatment, this will reduce and eventually halt eyelid twitching. Additionally, by manner of obstructing the nerve receptors located in the foot, spasticity induced deformity can be mitigated.

• Meditoxin® should only be applied on a patient by qualified, properly trained medical professionals.
• The product arrives packaged in a diluted form, contained within a sterile solution in preparation for injection.
• It is then injected directly into the muscular tissue which has been designated for treatment.

Contraindications:

• Hypersensitivity of treatment site.
• Myasthenia gravis or Eaton-Lambert syndrome, presence of infection at the proposed injection site.
• Acute UTI & acute urinary retention, in patients who are not routinely performing clean intermittent self-catheterization.

After-care:

• The patient is advised to not perform or partake in any physically taxing tasks, when undergoing treatment with Meditoxin®.
• The patient is also recommended to limit or avoid exposure to extreme cold and hot temperatures.
• The doctor might also provide to the patient some additional tips such as do’s and don’ts, when it comes to activities and beverage or food consumption.